Title |
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
|
---|---|
Published in |
JACC: CardioOncology, September 2019
|
DOI | 10.1016/j.jaccao.2019.08.003 |
Pubmed ID | |
Authors |
Ariane V.S. Macedo, Ludhmila A. Hajjar, Alexander R. Lyon, Bruno R. Nascimento, Alessandro Putzu, Lorenzo Rossi, Rafael B. Costa, Giovanni Landoni, Angélica Nogueira-Rodrigues, Antonio L.P. Ribeiro |
X Demographics
The data shown below were collected from the profiles of 161 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 33 | 20% |
Brazil | 17 | 11% |
United Kingdom | 10 | 6% |
Argentina | 7 | 4% |
Spain | 4 | 2% |
Japan | 4 | 2% |
Italy | 3 | 2% |
Australia | 2 | 1% |
Saudi Arabia | 2 | 1% |
Other | 23 | 14% |
Unknown | 56 | 35% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 107 | 66% |
Scientists | 26 | 16% |
Practitioners (doctors, other healthcare professionals) | 21 | 13% |
Science communicators (journalists, bloggers, editors) | 5 | 3% |
Unknown | 2 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 118 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 14% |
Student > Ph. D. Student | 13 | 11% |
Student > Bachelor | 12 | 10% |
Other | 9 | 8% |
Student > Postgraduate | 9 | 8% |
Other | 23 | 19% |
Unknown | 35 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 51 | 43% |
Biochemistry, Genetics and Molecular Biology | 9 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
Unspecified | 2 | 2% |
Nursing and Health Professions | 2 | 2% |
Other | 9 | 8% |
Unknown | 39 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 96. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2023.
All research outputs
#450,645
of 25,791,495 outputs
Outputs from JACC: CardioOncology
#25
of 477 outputs
Outputs of similar age
#9,542
of 358,089 outputs
Outputs of similar age from JACC: CardioOncology
#3
of 16 outputs
Altmetric has tracked 25,791,495 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 477 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,089 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.